| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $19.3M | — | +4.0% |
| Cost of Revenue | $3.5M | — | +24.4% |
| Gross Profit | $15.7M | — | +0.3% |
| R&D Expense | $5.6M | — | -10.4% |
| SG&A Expense | $6.1M | — | -5.1% |
| Operating Income | -$8.8M | — | +25.6% |
| Interest Expense | $1.4M | — | +15.5% |
| Pre-tax Income | -$10.6M | — | +23.3% |
| Income Tax | -$11K | — | -237.5% |
| Net Income | -$10.6M | — | +23.4% |
| EPS (Basic) | -$0.35 | — | +34.0% |
| EPS (Diluted) | -$0.35 | — | +34.0% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $8.3M | -18.9% | -44.1% |
| Short-term Investments | $6.0M | -25.1% | -45.6% |
| Accounts Receivable | $9.9M | +8.8% | -17.9% |
| Inventory | $6.1M | -11.7% | -27.1% |
| Current Assets | $31.6M | -10.8% | -34.0% |
| Total Assets | $51.5M |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$10.1M | — | +2.3% |
| Capital Expenditures | $19K | — | -91.4% |
| Investing Cash Flow | $2.0M | — | -81.0% |
| Financing Cash Flow | $6.1M | — | +1579.6% |
| Free Cash Flow | -$10.1M | — | +4.2% |
| -25.9% |
| Current Liabilities | $66.7M | +6.4% | +190.4% |
| Total Liabilities | $74.7M | +2.3% | +0.9% |
| Stockholders' Equity | -$23.2M | -39.1% | -406.8% |